Golimumab

No definition available.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries KELA purch., KELA reimb.

Medicine purchases: ATC L04AB06
Medicine purchases: ATC: other data required >3 instances required

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector RX_L04AB06

Extra metadata

First used in FinnGen datafreeze DF4

Summary Statistics

Key figures

All Female Male
Number of individuals 565 350 215
Unadjusted prevalence (%) 0.22 0.24 0.19
Mean age at first event (years) 46.70 47.15 45.96

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Correlations

Index endpoint: RX_L04AB06 – Golimumab
GWS hits:

Survival analyses between endpoints

Plot

before Golimumab
after Golimumab

loading spinner Loading survival analyses plot